Several global private equity firms are exploring a significant stake purchase in Agappe Diagnostics. This potential deal involves both exi...

Oxford's Ebola vaccine candidate has entered Phase 1 clinical trials for safety evaluation. The ChAdOx1 BDBV vaccine uses a platform simila...

Billions of mRNA vaccine doses administered globally confirm their safety and effectiveness against infectious diseases, including severe C...

An Ebola outbreak in Congo and Uganda has claimed over 200 lives. This is the worst outbreak at this stage, with thousands of potential con...

Chhattisgarh is fully prepared for potential virus infections. Health Minister Shyam Bihari Jaiswal assured that hospitals and quarantine f...

Eastern Congo faces a rapid Ebola outbreak. Women are primary caregivers, increasing their infection risk. Many lack protective gear, forci...

Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...

CEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...

A rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...

India is enhancing its surveillance protocols following an Ebola outbreak in the Democratic Republic of Congo and Uganda. One of two suspec...

India has provided crucial pharmaceutical supplies to aid the fight against the Ebola outbreak in Congo. The Africa Centres for Disease Con...

Christian missionary organisation Serge has said that the American doctor lived in the DRC with his wife Rebekah, also a medical practioner...

A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...

Ebola virus in Bangalore: A woman returning from Uganda was quarantined in Bengaluru with Ebola-like symptoms. Her tests have come back neg...

Ebola in India: The WHO has declared the Ebola outbreak in Congo and Uganda a public health emergency with over 300 cases and 88 deaths. In...

Researchers have developed a quick-acting Ebola vaccine that is both safe and effective with a single dose against the strain of the virus ...

The Ebola virus genetic material is delivered by a carrier virus (chimpanzee-derived adenovirus 3 or cAd 3) that causes a common cold in ch...